Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Capital Reinvestment Ratio
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Capital Reinvestment Ratio of 1.73x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥29.28 Million) in capital expenditures (CN¥50.59 Million). See Fujian Aonong Biological Technology Grou free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fujian Aonong Biological Technology Group Incorporation Ltd Capital Reinvestment Ratio (2013–2023)
This chart tracks Fujian Aonong Biological Technology Group Incorporation Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2023)
Year-by-year Capital Reinvestment Ratio for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2023. For live market cap and broader valuation context, see 603363 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.52x | CN¥984.01 Million | CN¥511.77 Million | ▼ -77.0% |
| 2022 | 2.26x | CN¥663.64 Million | CN¥1.50 Billion | ▼ -56.3% |
| 2021 | 5.17x | CN¥524.29 Million | CN¥2.71 Billion | ▼ -36.3% |
| 2020 | 8.11x | CN¥406.02 Million | CN¥3.29 Billion | ▲ +385.4% |
| 2019 | 1.67x | CN¥394.16 Million | CN¥658.44 Million | ▼ -92.0% |
| 2018 | 20.88x | CN¥27.26 Million | CN¥569.16 Million | ▲ +27.0% |
| 2017 | 16.44x | CN¥26.78 Million | CN¥440.19 Million | ▲ +668.7% |
| 2016 | 2.14x | CN¥128.95 Million | CN¥275.79 Million | ▲ +34.0% |
| 2015 | 1.60x | CN¥129.24 Million | CN¥206.25 Million | ▲ +201.1% |
| 2013 | 0.53x | CN¥137.26 Million | CN¥72.75 Million | — |